Overlap Weights for Binary Outcomes: A Performance Assessment.

IF 2.4 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Seo Young Park, Jaeil Ahn, Jae Hoon Lee, Jaewoo Kwon, Hana Lee
{"title":"Overlap Weights for Binary Outcomes: A Performance Assessment.","authors":"Seo Young Park, Jaeil Ahn, Jae Hoon Lee, Jaewoo Kwon, Hana Lee","doi":"10.1002/pds.70253","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Inverse probability weighting (IPW) is a widely used method to estimate the causal effect of treatment from observational data. However, it can be unstable when extreme propensity score (PS) values lead to very large weights. Overlap weights (OW), which emphasize subjects in areas of covariate overlap, reduce the influence of extreme PS without excluding participants. While the OW method has shown strong performance in simulations with continuous outcomes, its utility in binary outcome settings-common in health research-has not been thoroughly evaluated.</p><p><strong>Methods: </strong>We conducted simulation studies to evaluate the performance of OW in comparison to other PS weighting methods including IPW, trimmed IPW, and matching weights, in settings with extreme PS values and a binary outcome. Using simulated datasets with varying degrees of PS overlap and treatment prevalence, we assessed covariate balance and treatment effect estimation performance. The performance of the PS weighting methods was further illustrated through an application to data from a study on pancreatic ductal adenocarcinoma.</p><p><strong>Results: </strong>In simulation studies, IPW's performance deteriorated markedly as the overlap in the covariate distribution decreased. In contrast, OW achieved exact covariate balance and consistently showed the highest efficiency among all methods evaluated. In the application to real-world data characterized by low treatment prevalence and substantial covariate imbalance, OW also outperformed the other methods in terms of both standard error and covariate balance.</p><p><strong>Conclusion: </strong>These findings suggest superior performance of OW in terms of covariate balance and estimation efficiency in settings with extreme PS and a binary outcome.</p>","PeriodicalId":19782,"journal":{"name":"Pharmacoepidemiology and Drug Safety","volume":"34 11","pages":"e70253"},"PeriodicalIF":2.4000,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacoepidemiology and Drug Safety","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pds.70253","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Inverse probability weighting (IPW) is a widely used method to estimate the causal effect of treatment from observational data. However, it can be unstable when extreme propensity score (PS) values lead to very large weights. Overlap weights (OW), which emphasize subjects in areas of covariate overlap, reduce the influence of extreme PS without excluding participants. While the OW method has shown strong performance in simulations with continuous outcomes, its utility in binary outcome settings-common in health research-has not been thoroughly evaluated.

Methods: We conducted simulation studies to evaluate the performance of OW in comparison to other PS weighting methods including IPW, trimmed IPW, and matching weights, in settings with extreme PS values and a binary outcome. Using simulated datasets with varying degrees of PS overlap and treatment prevalence, we assessed covariate balance and treatment effect estimation performance. The performance of the PS weighting methods was further illustrated through an application to data from a study on pancreatic ductal adenocarcinoma.

Results: In simulation studies, IPW's performance deteriorated markedly as the overlap in the covariate distribution decreased. In contrast, OW achieved exact covariate balance and consistently showed the highest efficiency among all methods evaluated. In the application to real-world data characterized by low treatment prevalence and substantial covariate imbalance, OW also outperformed the other methods in terms of both standard error and covariate balance.

Conclusion: These findings suggest superior performance of OW in terms of covariate balance and estimation efficiency in settings with extreme PS and a binary outcome.

二元结果的重叠权值:一种性能评估。
背景:逆概率加权(IPW)是一种广泛使用的从观测数据估计治疗因果效应的方法。然而,当极端倾向得分(PS)值导致非常大的权重时,它可能是不稳定的。重叠权重(OW)强调协变量重叠区域的受试者,在不排除参与者的情况下减少极端PS的影响。虽然OW方法在具有连续结果的模拟中表现出很强的性能,但它在健康研究中常见的二元结果设置中的效用尚未得到彻底评估。方法:我们进行了模拟研究,以评估OW与其他PS加权方法(包括IPW、修剪IPW和匹配权重)在极端PS值和二元结果设置下的性能。利用不同PS重叠程度和治疗流行程度的模拟数据集,我们评估了协变量平衡和治疗效果估计性能。通过对胰腺导管腺癌研究数据的应用,进一步说明了PS加权方法的性能。结果:在模拟研究中,随着协变量分布的重叠减少,IPW的性能明显恶化。相比之下,OW达到了精确的协变量平衡,并且在所有评估的方法中始终显示出最高的效率。在应用于治疗患病率低、协变量失衡严重的现实数据时,OW在标准误差和协变量平衡方面也优于其他方法。结论:这些发现表明,在极端PS和二元结果的情况下,OW在协变量平衡和估计效率方面表现优异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.80
自引率
7.70%
发文量
173
审稿时长
3 months
期刊介绍: The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Report. Particular areas of interest include: design, analysis, results, and interpretation of studies looking at the benefit or safety of specific pharmaceuticals, biologics, or medical devices, including studies in pharmacovigilance, postmarketing surveillance, pharmacoeconomics, patient safety, molecular pharmacoepidemiology, or any other study within the broad field of pharmacoepidemiology; comparative effectiveness research relating to pharmaceuticals, biologics, and medical devices. Comparative effectiveness research is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition, as these methods are truly used in the real world; methodologic contributions of relevance to pharmacoepidemiology, whether original contributions, reviews of existing methods, or tutorials for how to apply the methods of pharmacoepidemiology; assessments of harm versus benefit in drug therapy; patterns of drug utilization; relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines; evaluations of risk management plans and programmes relating to pharmaceuticals, biologics and medical devices.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书